Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

2 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Epidemiological and clinical risk factors related to severe COVID-19 in Iran: a multi-center study.
Hashemi-Shahri SM, Tabatabaei SMN, Ansari-Moghaddam A, Mohammadi M, Okati-Aliabad H, Tabatabaei SM, Ansari H, Abbasi M, Sheikhzadeh K, Baygi MZ, Sartipi M, Sanei-Sistani S, Khorashad ARS, Ansari-Moghadam F, Torab N, Khalili T, Miri-Aliabad G. Hashemi-Shahri SM, et al. Among authors: khorashad ars. BMC Infect Dis. 2022 Feb 23;22(1):184. doi: 10.1186/s12879-022-07165-0. BMC Infect Dis. 2022. PMID: 35197013 Free PMC article.
Short-term celecoxib (celebrex) adjuvant therapy: a clinical trial study on COVID-19 patients.
Ghaznavi H, Mohammadghasemipour Z, Shirvaliloo M, Momeni MK, Metanat M, Gorgani F, Abedipour F, Mohammadi M, Sartipi M, Khorashad ARS, Shahraki O, Ataee M, Sheervalilou R, Sargazi S. Ghaznavi H, et al. Among authors: khorashad ars. Inflammopharmacology. 2022 Oct;30(5):1645-1657. doi: 10.1007/s10787-022-01029-4. Epub 2022 Jul 14. Inflammopharmacology. 2022. PMID: 35834150 Free PMC article.